This research-grade pentapeptide is supplied in a stable form designed for advanced laboratory and analytical applications
Introduction into humans or animals is strictly prohibited
Semaglutide and tirzepatide work by activating GLP-1 receptors in the pancreas to stimulate the production of insulin, which helps to control blood sugar levels in people with type 2 diabetes
Our KLOW protocol combines both (along with TB-500 and GHK-Cu) for exactly this reason
[12] [13] This mechanism may partially explain the metabolic improvements observed following bariatric surgery, where altered bile acid circulation enhances incretin responses
Studies in mice and humans showed that GLP-1 liraglutide acts directly and indirectly in LDL and VLDL catabolism, increases lipoprotein lipase gene expression responsible for TAG hydrolysis, and reduces apolipoprotein B48, diacylglycerol O -acyltransferase 1, and microsomal transfer protein gene expression, all of which are involved in chylomicron synthesis [77, 78]